Asset Management
Compare Stocks
2 / 10Stock Comparison
BN vs MS
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
BN vs MS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Financial - Capital Markets |
| Market Cap | $104.26B | $307.53B |
| Revenue (TTM) | $77.66B | $103.14B |
| Net Income (TTM) | $1.31B | $16.18B |
| Gross Margin | 40.0% | 55.6% |
| Operating Margin | 39.9% | 17.1% |
| Forward P/E | 16.7x | 16.3x |
| Total Debt | $263.42B | $360.49B |
| Cash & Equiv. | $16.24B | $75.74B |
BN vs MS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Brookfield Corporat… (BN) | 100 | 272.8 | +172.8% |
| Morgan Stanley (MS) | 100 | 437.3 | +337.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BN vs MS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BN is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.57, current ratio 1.14x
- Efficiency ratio 0.0% vs MS's 0.4% (lower = leaner)
- Efficiency ratio 0.0% vs MS's 0.4%
MS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 11 yrs, beta 1.37, yield 2.0%
- Rev growth 16.8%, EPS growth 53.5%
- 7.4% 10Y total return vs BN's 305.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.8% NII/revenue growth vs BN's -9.7% | |
| Value | Lower P/E (16.3x vs 16.7x) | |
| Quality / Margins | Efficiency ratio 0.0% vs MS's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 1.37 vs BN's 1.57 | |
| Dividends | 2.0% yield; 11-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +66.7% vs BN's +28.5% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs MS's 0.4% |
BN vs MS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BN vs MS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — BN and MS each lead in 2 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
MS and BN operate at a comparable scale, with $103.1B and $77.7B in trailing revenue. MS is the more profitable business, keeping 13.0% of every revenue dollar as net income compared to BN's 1.7%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $77.7B | $103.1B |
| EBITDAEarnings before interest/tax | $32.1B | $26.3B |
| Net IncomeAfter-tax profit | $1.3B | $16.2B |
| Free Cash FlowCash after capex | -$2.8B | -$6.7B |
| Gross MarginGross profit ÷ Revenue | +40.0% | +55.6% |
| Operating MarginEBIT ÷ Revenue | +39.9% | +17.1% |
| Net MarginNet income ÷ Revenue | +1.7% | +13.0% |
| FCF MarginFCF ÷ Revenue | — | -2.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +73.1% | +48.9% |
Valuation Metrics
BN leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 24.3x trailing earnings, MS trades at a 100% valuation discount to BN's 9999.0x P/E. On an enterprise value basis, BN's 8.5x EV/EBITDA is more attractive than MS's 26.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $104.3B | $307.5B |
| Enterprise ValueMkt cap + debt − cash | $351.4B | $592.3B |
| Trailing P/EPrice ÷ TTM EPS | 9999.00x | 24.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.66x | 16.28x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.73x |
| EV / EBITDAEnterprise value multiple | 8.52x | 26.03x |
| Price / SalesMarket cap ÷ Revenue | 1.34x | 2.98x |
| Price / BookPrice ÷ Book value/share | 0.66x | 2.95x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
BN leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
MS delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $1 for BN. BN carries lower financial leverage with a 1.59x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 3.42x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +0.8% | +14.6% |
| ROA (TTM)Return on assets | +0.3% | +1.2% |
| ROICReturn on invested capital | +5.6% | +2.9% |
| ROCEReturn on capital employed | +7.2% | +3.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 1.59x | 3.42x |
| Net DebtTotal debt minus cash | $247.2B | $284.7B |
| Cash & Equiv.Liquid assets | $16.2B | $75.7B |
| Total DebtShort + long-term debt | $263.4B | $360.5B |
| Interest CoverageEBIT ÷ Interest expense | 1.64x | 0.44x |
Total Returns (Dividends Reinvested)
MS leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MS five years ago would be worth $24,217 today (with dividends reinvested), compared to $19,191 for BN. Over the past 12 months, MS leads with a +66.7% total return vs BN's +28.5%. The 3-year compound annual growth rate (CAGR) favors MS at 34.3% vs BN's 30.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -0.2% | +7.4% |
| 1-Year ReturnPast 12 months | +28.5% | +66.7% |
| 3-Year ReturnCumulative with dividends | +121.8% | +142.1% |
| 5-Year ReturnCumulative with dividends | +91.9% | +142.2% |
| 10-Year ReturnCumulative with dividends | +305.3% | +739.4% |
| CAGR (3Y)Annualised 3-year return | +30.4% | +34.3% |
Risk & Volatility
MS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MS is the less volatile stock with a 1.37 beta — it tends to amplify market swings less than BN's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 99.2% from its 52-week high vs BN's 93.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.57x | 1.37x |
| 52-Week HighHighest price in past year | $49.57 | $194.83 |
| 52-Week LowLowest price in past year | $35.95 | $117.21 |
| % of 52W HighCurrent price vs 52-week peak | +93.7% | +99.2% |
| RSI (14)Momentum oscillator 0–100 | 59.8 | 61.2 |
| Avg Volume (50D)Average daily shares traded | 5.9M | 5.4M |
Analyst Outlook
MS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates BN as "Buy" and MS as "Buy". Consensus price targets imply 17.1% upside for BN (target: $54) vs 6.5% for MS (target: $206). MS is the only dividend payer here at 1.97% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $54.40 | $205.75 |
| # AnalystsCovering analysts | 9 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% |
| Dividend StreakConsecutive years of raises | 1 | 11 |
| Dividend / ShareAnnual DPS | — | $3.81 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% |
MS leads in 3 of 6 categories (Total Returns, Risk & Volatility). BN leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
BN vs MS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BN or MS a better buy right now?
For growth investors, Morgan Stanley (MS) is the stronger pick with 16.
8% revenue growth year-over-year, versus -9. 7% for Brookfield Corporation (BN). Morgan Stanley (MS) offers the better valuation at 24. 3x trailing P/E (16. 3x forward), making it the more compelling value choice. Analysts rate Brookfield Corporation (BN) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BN or MS?
On trailing P/E, Morgan Stanley (MS) is the cheapest at 24.
3x versus Brookfield Corporation at 9999. 0x. On forward P/E, Morgan Stanley is actually cheaper at 16. 3x.
03Which is the better long-term investment — BN or MS?
Over the past 5 years, Morgan Stanley (MS) delivered a total return of +142.
2%, compared to +91. 9% for Brookfield Corporation (BN). Over 10 years, the gap is even starker: MS returned +739. 4% versus BN's +305. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BN or MS?
By beta (market sensitivity over 5 years), Morgan Stanley (MS) is the lower-risk stock at 1.
37β versus Brookfield Corporation's 1. 57β — meaning BN is approximately 14% more volatile than MS relative to the S&P 500. On balance sheet safety, Brookfield Corporation (BN) carries a lower debt/equity ratio of 159% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.
05Which is growing faster — BN or MS?
By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 16.
8% versus -9. 7% for Brookfield Corporation (BN). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 53. 5% year-over-year, compared to -99. 8% for Brookfield Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BN or MS?
Morgan Stanley (MS) is the more profitable company, earning 13.
0% net margin versus 1. 7% for Brookfield Corporation — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BN leads at 39. 9% versus 17. 1% for MS. At the gross margin level — before operating expenses — MS leads at 55. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BN or MS more undervalued right now?
On forward earnings alone, Morgan Stanley (MS) trades at 16.
3x forward P/E versus 16. 7x for Brookfield Corporation — 0. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BN: 17. 1% to $54. 40.
08Which pays a better dividend — BN or MS?
In this comparison, MS (2.
0% yield) pays a dividend. BN does not pay a meaningful dividend and should not be held primarily for income.
09Is BN or MS better for a retirement portfolio?
For long-horizon retirement investors, Morgan Stanley (MS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2.
0% yield, +739. 4% 10Y return). Brookfield Corporation (BN) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MS: +739. 4%, BN: +305. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BN and MS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BN is a mid-cap quality compounder stock; MS is a large-cap high-growth stock. MS pays a dividend while BN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.